Issue 000 | U.S. Pilot | US

SBFM

Sunshine Biopharma Inc.

Passing Verified 10-Q | 2026-05-13 Filing currency: USD
Margin of Safety 43.6%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
24,783,176USD
Total Liabilities
6,413,781USD
NCAV
18,369,395USD
Cash
n/a
NCAV per share
3.74USD/share
Evidence
10 annual | 20 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one SBFM, then regenerate the site.

Known Unknowns

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue 36,305,891 34,874,283 24,092,787 4,345,603 228,426 71,410 21,121 447,200 0 n/a
Operating Income -6,227,029 -5,812,121 -4,785,299 -27,000,750 -2,440,134 -576,874 -641,636 -1,166,537 -857,190 -993,108
Net Income -5,975,352 -5,134,116 -4,506,044 -26,744,440 -12,436,447 -2,784,091 -1,660,291 -2,156,155 -1,040,236 -3,496,687
Cash From Operations -5,331,073 -12,531,180 -8,775,111 -5,248,358 -1,829,128 -657,299 -495,798 -512,806 -543,520 -314,182
Capex -174,491 -1,657,055 -82,251 -193,982 0 -1,191 -860 -18,850 -3,718 -3,439
Free Cash Flow -5,505,564 -14,188,235 -8,857,362 -5,442,340 -1,829,128 -658,490 -496,658 -531,656 -547,238 -317,621
Cash And Equivalents n/a n/a n/a 21,826,437 2,045,167 989,888 40,501 115,216 107,532 57,453
Accounts Receivable 3,459,864 3,868,418 2,552,362 1,912,153 7,798 1,916 430 94,955 0 n/a
Inventory 13,472,025 11,278,105 5,734,755 3,289,945 105,650 23,771 15,910 0 n/a n/a
Total Current Assets 26,853,581 25,966,349 24,890,055 27,312,334 2,195,830 1,025,943 65,686 211,512 117,199 58,460
Total Assets 30,079,167 30,560,392 27,346,961 29,243,848 2,202,891 1,045,474 98,142 1,146,571 257,485 64,404
Total Current Liabilities 6,443,922 6,314,914 5,551,836 6,931,014 91,229 1,051,305 833,527 912,477 751,138 274,104
Total Liabilities 7,040,707 7,059,638 6,139,600 7,616,278 1,991,229 2,000,311 833,527 1,202,324 830,848 274,104
Shareholders Equity 23,038,460 23,500,754 21,207,361 21,627,570 211,662 -954,837 -735,385 -55,753 -573,363 -209,700
Shares Outstanding 4,905,945 2,580,098 28,024,290 22,585,632 2,591,240 346,419,296 35,319,990 85,652,400 918,736,498 769,399,858
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted n/a 701,749 24,331,908 15,180,868 2,612,061 n/a n/a n/a n/a n/a
Weighted Avg Shares Basic 4,157,086 701,749 24,331,908 15,180,868 2,612,061 204,096,338 10,932,813 60,936,164 872,685,608 424,874,458
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue 8,088,765 8,577,141 9,417,179 9,410,230 8,901,341 9,594,992 8,435,178 9,303,067 7,541,046 7,680,201 5,957,668 5,560,865 4,894,053 3,939,843 132,808 150,307 122,645 85,118 50,376 52,874
Operating Income -1,395,597 -1,790,011 -1,086,613 -2,054,655 -1,295,750 -2,037,722 -1,106,353 -1,317,457 -1,350,589 -1,187,221 -779,474 -989,623 -1,828,981 -23,363,610 -1,717,980 -695,796 -1,223,364 -279,631 -496,259 -388,598
Net Income -1,243,869 -2,140,927 -883,820 -1,770,834 -1,179,771 -2,158,212 -1,197,803 -494,300 -1,283,801 -1,250,024 -651,482 -902,108 -1,702,430 -23,512,315 -1,457,019 -538,872 -1,236,234 667,116 -4,039,383 -2,879,054
Cash From Operations -2,072,100 -1,616,006 -727,800 -1,273,432 -1,713,835 -3,407,282 -1,360,956 -4,577,783 -3,185,159 -2,689,676 -457,289 -3,778,040 -1,850,106 -2,246,612 -1,123,736 -573,802 -1,304,208 -312,113 -600,808 -618,852
Capex -5,129 1,039 -8,040 -160,000 -7,490 -102,600 -517,005 -974,513 -62,937 n/a -9,634 n/a n/a n/a 0 n/a n/a n/a n/a n/a
Free Cash Flow -2,077,229 -1,614,967 -735,840 -1,433,432 -1,721,325 -3,509,882 -1,877,961 -5,552,296 -3,248,096 n/a -466,923 n/a n/a n/a -1,123,736 n/a n/a n/a n/a n/a
Cash And Equivalents n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 19,729,491 19,294,218 21,826,437 40,555,931 41,727,775 13,177,625 2,045,167 2,386,608 1,735,094
Total Current Assets 24,783,176 26,853,581 27,967,232 27,851,018 24,480,980 25,966,349 25,981,863 25,748,520 28,831,224 24,890,055 25,434,859 26,098,709 24,946,947 27,312,334 40,860,574 41,989,322 13,405,367 2,195,830 2,491,683 1,803,586
Total Liabilities 6,413,781 7,040,707 7,288,023 6,280,446 6,484,635 7,059,638 5,017,504 5,811,114 7,079,102 6,139,600 5,686,801 5,300,229 7,561,870 7,616,278 480,209 104,684 95,234 1,991,229 3,675,847 2,689,778
Shares Outstanding 4,905,945 4,905,945 4,555,945 4,555,945 2,707,541 2,580,098 1,999,660 1,170,510 994,529 28,024,290 25,678,290 25,746,302 22,139,921 22,585,632 18,885,632 18,885,632 7,149,778 2,591,240 510,093,265 486,093,265
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted n/a n/a 3,925,235 3,604,653 2,703,293 701,749 1,267,565 49,726 641,310 24,331,908 25,690,449 25,350,263 22,036,272 15,180,868 18,885,632 15,849,518 5,272,856 2,612,061 n/a n/a
Weighted Avg Shares Basic 4,905,945 4,157,086 4,555,945 4,496,108 2,703,293 701,749 1,267,565 49,726 641,310 24,331,908 25,690,449 25,350,263 220,363 15,180,868 18,885,632 15,849,518 5,272,856 2,612,061 508,528,048 478,520,336
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 24,783,176USD us-gaap:AssetsCurrent 2026-03-31 1.00 sec/companyfacts/cik=0001402328/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001402328\companyfacts.json
Total Liabilities 6,413,781USD us-gaap:Liabilities 2026-03-31 1.00 sec/companyfacts/cik=0001402328/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001402328\companyfacts.json
Cash n/a derived 2026-03-31 n/a n/a
Shares Outstanding 4,905,945 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 sec/companyfacts/cik=0001402328/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001402328\companyfacts.json
NCAV 18,369,395USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 3.74USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 43.6% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
CIK
0001402328
Company ID
n/a
Selected Annual Source
n/a
Selected Quarterly Source
n/a
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
25
Imported At
2026-07-04T23:04:38+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001683168-26-003819
CIK
0001402328
Mary Filing Date
2026-05-13
Filing Currency
USD
Internal Discount
43.6%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-13; mary_accession=0001683168-26-003819; mary_cik=0001402328; gnni_supporting_filing_date=2026-05-13; internal_discount=0.436479; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Archive